Restricted accessResearch articleFirst published online 2024-3
899 serious adverse events including 13 deaths,7 strokes,211 thromboembolic events,and 482 immune reactions: The untold story of cyanoacrylate adhesive closure
The aim was to retrieve and analyse the serious adverse events of venous occlusion systems used in cyanoacrylate adhesive closure (CAC) submitted to regulatory agencies.
Methods
The Total Product Life Cycle (TPLC) database of the US Food and Drug Administration (FDA), the Database of Adverse Event Notifications (DAEN) of the Australian Therapeutic Goods Administration (TGA), and the Yellow Card database of the UK Medicines and Healthcare Products Regulatory Agency (MHRA) were reviewed. Three Freedom of Information (FOI) requests had to be submitted to the MHRA to obtain data.
Results
The TPLC contained 899 reports which included 13 cases of death, 7 strokes, 211 thromboembolic events, and 482 immune reactions. The DAEN recorded three reportable adverse events, and the MHRA recorded seven adverse incidents including one death.
Conclusion
CAC is associated with serious adverse events including death. These events are under-reported in the medical literature and only sub-optimally reported to the regulatory agencies.
AlmeidaJIJavierJJMackayE, et al.First human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord2013; 1: 174–180.
2.
GibsonKFerrisB. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: initial outcomes of a post-market evaluation of the venaseal system (the WAVES study). Vascular2017; 25: 149–156.
3.
MorrisonNGibsonKVasquezM, et al.Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord2020; 8: 978–989.
4.
ProebstleTAlmJDimitriS, et al.Three-year follow-up results of the prospective european multicenter cohort study on cyanoacrylate embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord2021; 9: 329–334.
5.
MorrisonNGibsonKMcEnroeS, et al.Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg2015; 61: 985–994.
6.
ProebstleTMAlmJDimitriS, et al.The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord2015; 3: 2–7.
AthavaleAThaoMSassakiVS, et al.Cyanoacrylate glue reactions: a systematic review, cases, and proposed mechanisms. J Vasc Surg Venous Lymphat Disord2023; 11: 876–888. Epub ahead of print 10 April 2023. DOI: 10.1016/j.jvsv.2023.03.018.
9.
LangridgeBJOnidaSWeirJ, et al.Cyanoacrylate glue embolisation for varicose veins - a novel complication. Phlebology2020; 35: 520–523.
10.
NguyenJKRobertsSLeeA. Allergic contact dermatitis caused by n-butyl-2-cyanoacrylate in venablock vein glue. Phlebology2023; 38: 352–353.
11.
ChenOHajianHVarcoeRL, et al.Infective thrombophlebitis after great saphenous vein cyanoacrylate embolization. J Vasc Surg Cases Innov Tech2021; 7: 577–580.
12.
ParsiKKangMYangA, et al.Granuloma formation following cyanoacrylate glue injection in peripheral veins and arteriovenous malformation. Phlebology2020; 35: 115–123.
13.
NasserHIvanicsTShakarounD, et al.Severe phlebitis-like abnormal reaction following great saphenous vein cyanoacrylate closure. J Vasc Surg Venous Lymphat Disord2019; 7: 578–582.
14.
AlmeidaJIMurraySPRomeroME. Saphenous vein histopathology 5.5 years after cyanoacrylate closure. J Vasc Surg Venous Lymphat Disord2020; 8: 280–284.
15.
JonesADBoyleEMWoltjerR, et al.Persistent type IV hypersensitivity after cyanoacrylate closure of the great saphenous vein. J Vasc Surg Cases Innov Tech2019; 5: 372–374.
16.
NishizawaMKudoT. Septicemia after cyanoacrylate glue closure of varicose veins. J Vasc Surg Cases Innov Tech2022; 8: 653–656.
17.
FiengoLGwozdzATincknellL, et al.VenaSeal closure despite allergic reaction to n-butyl cyanoacrylate. J Vasc Surg Cases Innov Tech2020; 6: 269–271.
18.
ZernovickyF. Fast progressive devastating granulomatic reaction after venaseal procedure. Int Angiol2018; 37: 168–169.
19.
StokbroekxTde BoerAVerdaasdonkRM, et al.Commonly used fiber tips in endovenous laser ablation (EVLA): an analysis of technical differences. Laser Med Sci2014; 29: 501–507.
20.
ParsiKRobertsSKangM, et al.Cyanoacrylate closure for peripheral veins: consensus document of the Australasian college of phlebology. Phlebology2020; 35: 153–175.
21.
CombyP-OGuillenKChevallierO, et al.Endovascular use of cyanoacrylate-lipiodol mixture for peripheral embolization: properties, techniques, pitfalls, and applications. J Clin Med2021; 10: 4320.
22.
GraceJConnorDEBesterLJ, et al.Polymerisation of cyanoacrylates: the effect of sclero-embolic and contrast agents. Phlebology. in press.
Medicines & Health products Regulatory Agency. Yellow Card | Making medicines and medical devices safer, https://yellowcard.mhra.gov.uk/ (accessed 23 May 2023).
29.
NguyenCNNguyenQ-BDSilapuntS. Analysis of adverse events with sclerosants reported to the United States food and drug administration. Phlebology2022; 37: 452–459.
30.
Medicines & Health products Regulatory Agency. Yellow Card | Making medicines and medical devices safer, https://yellowcard.mhra.gov.uk/ (accessed 20 June 2023).
31.
WhingJNandhraSNesbittC, et al.Interventions for great saphenous vein incompetence. Cochrane Database Syst Rev2021; 8: CD005624.
32.
KelesEBozokS. How innocent is using glue treatment for venous insufficiency? complications. Phlebology2022; 37: 8.
33.
MurzinaELobastovK. Long-term results of cyanoacrylate embolization of saphenous veins. Phlebology. 2022; 37(2): 90.
34.
O’BanionLAASiadaSCutlerB, et al.Thrombotic complications after radiofrequency and cyanoacrylate endovenous ablation: outcomes of a multicenter real-world experience. J Vasc Surg Venous Lymphat Disord2022; 10: 1221–1228.
35.
TangTYRathnaweeraHPKamJW, et al.Endovenous cyanoacrylate glue to treat varicose veins and chronic venous insufficiency-experience gained from our first 100+ truncal venous ablations in a multi-ethnic asian population using the medtronic VenaSealTM closure system. Phlebology2019; 34: 543–551.
36.
ChanSSJYapCJQTanSG, et al.The utility of endovenous cyanoacrylate glue ablation for incompetent saphenous veins in the setting of venous leg ulcers. J Vasc Surg Venous Lymphat Disord2020; 8: 1041–1048.
37.
KoreptaLWardMBlechaM, et al.A contemporary comparison of cyanoacrylate, radiofrequency, and endovenous laser ablation on healing of active venous ulceration. Ann Vasc Surg2022; 87: 237–244.
38.
NovotnýKRočekMPádrR, et al.Treating great and small saphenous vein insufficiency with histoacryl in patients with symptomatic varicose veins and increased risk of surgery. Vasa2018; 47: 416–424.
39.
YiğitG. Outcomes of cyanoacrylate closure of the truncal varicose vein insufficiency: a comparison between young and elderly patients. Phlebology2023; 38: 119–128.
AlmeidaJIJavierJJMackayEG, et al.Three-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord2015; 3: 125.
43.
GibsonKMorrisonNKolluriR, et al.Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord2018; 6: 606–613.
44.
ParkIJeongMHParkCJ, et al.Clinical features and management of ‘phlebitis-like abnormal reaction’ after cyanoacrylate closure for the treatment of incompetent saphenous veins. Ann Vasc Surg2019; 55: 239–245.
45.
KelesE. Complications of cyanoacrylate adhesive closure therapy in chronic venous insufficiency: a single center, single-surgeon study. Phlebology2023; 38: 550–555.
46.
O’BanionLAAShaoMYAliA, et al.Type IV hypersensitivity reaction after cyanoacrylate venous closure. Ann Vasc Surg2023; 95: 218–223.
Medicines & Health products Regulatory Agency. Medical device adverse incidents | Making medicines and medical devices safer, https://yellowcard.mhra.gov.uk/medicaldevices (accessed 22 May 2023).
50.
BrothersMFKaufmannJCFoxAJ, et al.n-Butyl 2-cyanoacrylate--substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. Am J Neuroradiol1989; 10: 777–786.
51.
WhiteRIStrandbergJVGrossGS, et al.Therapeutic embolization with long-term occluding agents and their effects on embolized tissues. Radiology1977; 125: 677–687.
52.
VintersHVGalilKALundieMJ, et al.The histotoxicity of cyanoacrylates. a selective review. Neuroradiology1985; 27: 279–291.
AlmJ. Ausschaltung der stammvarikose mit kleberindikation. Gefässchirurgie2014; 19: 629–636.
55.
AthavaleAFukayaESassakiVS. Rare adverse event following cyanoacrylate closure of greater saphenous vein. Vasc Med. 2022; 27: NP7-8.
56.
Au-YeungCLKTseOHRPangYCS, et al.Review of thermal and non-thermal based endovenous treatment: our local experience. Surg Pract2020; 24: 151–155.
57.
BademciMŞKocaaslanCAldagM, et al.Single-center retrospective review of early outcomes of radiofrequency ablation versus cyanoacrylate ablation of isolated great saphenous vein insufficiency. J Vasc Surg Venous Lymphat Disord2019; 7: 480–485.
58.
Bellam PremnathKPJoyBRaghavendraVA, et al.Cyanoacrylate adhesive embolization and sclerotherapy for primary varicose veins. Phlebology2018; 33: 547–557.
59.
BianchiPGPalombiL. Evolution of endovascular vein procedures: glue embolization of perforator veins with direct puncture-technique. Monocentric initial experience. Phlebology; 37: 208.
60.
BozkurtAKYılmazMF. A prospective comparison of a new cyanoacrylate glue and laser ablation for the treatment of venous insufficiency. Phlebology2016; 31: 106–113.
61.
CantürkE. Comparison of glue ablation and endovenous thermal ablation of small saphenous vein and early and midterm results. J Exp Clin Med2019; 35: 41–44.
62.
ChanSSTangTYChongTT, et al.Retrograde technique for great saphenous vein ablation using the VenaSealTM closure system – ideal approach for deep seated or small below the knee refluxing truncal veins. Phlebology2020; 35: 102–109.
63.
ChanYCLawYCheungGC, et al.Predictors of recanalization for incompetent great saphenous veins treated with cyanoacrylate glue. J Vasc Interv Radiol JVIR2017; 28: 665–671.
64.
ChoSGibsonKLeeSH, et al.Incidence, classification, and risk factors of endovenous glue-induced thrombosis after cyanoacrylate closure of the incompetent saphenous vein. J Vasc Surg Venous Lymphat Disord2020; 8: 991–998.
65.
ChoSJohJH. Cyanoacrylate closure of small saphenous vein insufficiency. Dermatol Surg Off Publ Am Soc Dermatol Surg Al2021; 47: 381–384.
66.
ChoSJohJH. Changes of stump length depending on starting position of glue injection related to venous diameter during cyanoacrylate closure for incompetent saphenous veins. J Vasc Surg Venous Lymphat Disord2022; 10: 376–381.
67.
DaylanAİslamoğluF. Comparative analysis of the results of cyanoacrylate ablation and radiofrequency ablation in the treatment of venous insufficiency. J Vasc Surg Venous Lymphat Disord2022; 10: 661–668.e2.
68.
JohJHChoS. VESS08. Incidence, classification, and risk factors of endovenous glue-induced thrombosis after cyanoacrylate closure of varicose vein. J Vasc Surg2019; 69: e57–e58.
69.
JohJHLeeTByunSJ, et al.A multicenter randomized controlled trial of cyanoacrylate closure and surgical stripping for incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord2022; 10: 353–359.
70.
JohJHParkHC. Risk factor of the phlebitis after cyanoacrylate closure for varicose veins. Vascular. 2017; 25: 61–62.
71.
KolluriRGibsonKCherD, et al.Roll-in phase analysis of clinical study of cyanoacrylate closure for incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord2016; 4: 407–415.
72.
LeeSYPangYCTangCN. Injection of cyanoacrylate glue: a safe and effective office procedure for management of varicose veins. Surg Pract2016; 20: 21–44.
73.
MiyagawaHSakakibaraNYahiR, et al. Venous hypertension as a risk factor of unsuccessful cyanoacrylate adhesive closure. Phlebology. 2022; 37: 34–35.
74.
PaveiPFerriniMGiraldiE, et al. The treatment of great and small saphenous vein insufficiency using cyanoacrylate glue: my experience. International Angiology, 2018, 37, p. 76.
75.
PillutlaAHendrixMPHaJ. Endovenous glue-induced thrombosis in nonthermal glue closure therapy for greater saphenous vein insufficiency: a single-center experience. J Vasc Interv Radiol JVIR2019; 30: 1075–1080.
76.
QiXZhangMYuW, et al.Early results of cyanoacrylate adhesive ablation versus laser ablation for the treatment of great saphenous vein insufficiency in the Chinese mainland population. Phlebology2023; 38: 157–164.
77.
SakakibaraNYagiRImaiT, et al. Non catheter-based cyanoacrylate embolization for tortuous great saphenous veins. Phlebology. 2018; 37(1S): 26–27.
78.
SanbaevA. The results of a histological study of the vein of a patient with varicose veins of the lower extremities after cyanoacrylate obliteration. Phlebology; 37: 187–188.
79.
SermsathanasawadiNPruekprasertKChinsakchaiK, et al.Cyanoacrylate granuloma after cyanoacrylate closure of incompetent saphenous veins. Dermatol Surg2021; 47: 1372.
80.
SermsathanasawadiNPruekprasertKPrapassaroT, et al.Thrombus extension after cyanoacrylate closure of incompetent saphenous veins. Int Angiol J Int Union Angiol2022; 41: 143–148.
81.
SumarliSALeeQWSYapHY, et al.Exit site complications following cyanoacrylate glue endovenous ablation of incompetent truncal veins for chronic venous insufficiency. J Vasc Surg Cases Innov Tech2020; 6: 500–504.
82.
TangTYRathnaweeraHPChokeE, et al.Institution of a double-dosing protocol using cyanoacrylate glue for larger diameter refluxing superficial truncal veins. Dermatol Surg2019; 45: 1426.
83.
TangTYYapCJQChanSL, et al.Early results of an Asian prospective multicenter VenaSeal real-world postmarket evaluation to investigate the efficacy and safety of cyanoacrylate endovenous ablation for varicose veins. J Vasc Surg Venous Lymphat Disord2021; 9: 335–345.e2.
84.
TekinAİTuncerONMemetoğluME, et al.Nonthermal, Nontumescent Endovenous Treatment of Varicose Veins. Ann Vasc Surg2016; 36: 231–235.
85.
Vicente-JiménezSLopez-ValcarcelBMaynarM, et al.Clinical results and cost-effectiveness of radiofrequency and cyanoacrylate ablation compared with traditional surgical stripping for treating varicose veins. J Vasc Surg Venous Lymphat Disord2022; 10: 846–854.e2.
86.
WeaverIWeaverPWeaverI, et al.Audit of the efficacy and complications of cyanoacrylate glue embolisation to treat varicose veins in primary care. J Prim Health Care2019; 11: 249–258.
87.
YangGKParapiniMGagnonJ, et al.Comparison of cyanoacrylate (VenaSeal) and radiofrequency ablation for treatment of varicose veins in a canadian population. J Vasc Surg2017; 66: e48–e49.
88.
YiğitG. How effective is cyanoacrylate closure in small saphenous vein insufficiency? a single center experience. Vascular2022; 30: 1182–1188.
